Western University

Scholarship@Western
Neuroscience Institute Publications

Western Institute for Neuroscience

8-1-2022

International Union of Angiology (IUA) consensus paper on
imaging strategies in atherosclerotic carotid artery imaging: From
basic strategies to advanced approaches
Luca Saba
Azienda Ospedaliero Universitaria di Cagliari

Pier Luigi Antignani
Vascular Center

Ajay Gupta
Weill Cornell Medicine

Riccardo Cau
Azienda Ospedaliero Universitaria di Cagliari

Kosmas I. Paraskevas
Central Clinic of Athens

See next page for additional authors
Follow this and additional works at: https://ir.lib.uwo.ca/neurosci_inst_pubs

Citation of this paper:
Saba, Luca; Antignani, Pier Luigi; Gupta, Ajay; Cau, Riccardo; Paraskevas, Kosmas I.; Poredos, Pavel;
Wasserman, Bruce; Kamel, Hooman; Avgerinos, Efthymios D.; Salgado, Rodrigo; Caobelli, Federico; Aluigi,
Leonardo; Savastano, Luis; Brown, Martin; Hatsukami, Tom; Hussein, Emad; Suri, Jasjit S.; Mansilha,
Armado; Wintermark, Max; Staub, Daniel; Montequin, Jose Fernandes; Rodriguez, Ruben Tomas Toro;
Balu, Niranjan; Pitha, Jan; Kooi, M. Eline; Lal, Brajesh K.; Spence, J. David; Lanzino, Giuseppe; Marcus,
Hugh Stephen; and Mancini, Marcello, "International Union of Angiology (IUA) consensus paper on
imaging strategies in atherosclerotic carotid artery imaging: From basic strategies to advanced
approaches" (2022). Neuroscience Institute Publications. 52.
https://ir.lib.uwo.ca/neurosci_inst_pubs/52

Authors
Luca Saba, Pier Luigi Antignani, Ajay Gupta, Riccardo Cau, Kosmas I. Paraskevas, Pavel Poredos, Bruce
Wasserman, Hooman Kamel, Efthymios D. Avgerinos, Rodrigo Salgado, Federico Caobelli, Leonardo Aluigi,
Luis Savastano, Martin Brown, Tom Hatsukami, Emad Hussein, Jasjit S. Suri, Armado Mansilha, Max
Wintermark, Daniel Staub, Jose Fernandes Montequin, Ruben Tomas Toro Rodriguez, Niranjan Balu, Jan
Pitha, M. Eline Kooi, Brajesh K. Lal, J. David Spence, Giuseppe Lanzino, Hugh Stephen Marcus, and
Marcello Mancini

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/neurosci_inst_pubs/52

Atherosclerosis 354 (2022) 23–40

Contents lists available at ScienceDirect

Atherosclerosis
journal homepage: www.elsevier.com/locate/atherosclerosis

Review article

International Union of Angiology (IUA) consensus paper on imaging
strategies in atherosclerotic carotid artery imaging: From basic strategies to
advanced approaches☆
Luca Saba a, *, Pier Luigi Antignani b, Ajay Gupta c, Riccardo Cau a, Kosmas I. Paraskevas d,
Pavel Poredos e, ab, Bruce A. Wasserman f, Hooman Kamel g, Efthymios D. Avgerinos h, ac,
Rodrigo Salgado i, Federico Caobelli j, Leonardo Aluigi k, Luis Savastano l, Martin Brown m,
Tom Hatsukami n, Emad Hussein o, Jasjit S. Suri p, ad, ae, Armado Mansilha q, Max Wintermark r,
Daniel Staub s, Jose Fernandes Montequin t, Ruben Tomas Toro Rodriguez t, Niranjan Balu n,
Jan Pitha u, M. Eline Kooi v, Brajesh K. Lal w, af, J. David Spence x, Giuseppe Lanzino u,
Hugh Stephen Marcus y, Marcello Mancini z, Seemant Chaturvedi aa, Ales Blinc e
a

Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari – Polo di Monserrato s.s. 554 Monserrato, Cagliari, 09045, Italy
Vascular Center, Nuova Villa Claudia, Rome, Italy
c
Department of Radiology Weill Cornell Medical College, New York, NY, USA
d
Department of Vascular Surgery, Central Clinic of Athens, Athens, Greece
e
Department of Vascular Disease, University Medical Center Ljubljana, Zaloska cesta 2, 1000, Ljubljana, Slovenia
f
The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, 367 East Park Building, 600 N Wolfe St, Baltimore, MD, 21287,
USA
g
Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, Department of Neurology, Weill Cornell Medicine, New York, USA
h
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa, USA
i
Department of Radiology, Antwerp University Hospital (UZA), Edegem, Belgium
j
University Clinic of Nuclear Medicine, Inselspital, University Hospital Bern, Bern, Switzerland
k
Angiology Care Unit, Private Villalba Hospital (GVM), Bologna, Italy
l
Neurosurgery, Mayo Clinic, Rochester, MN, USA
m
Department of Neurology and Neurosurgery, University College London Hospitals, London, UK
n
Department of Surgery, University of Washington, Seattle, WA, USA
o
Vascular surgery Department, Ain Shams University, Cairo, Egypt
p
Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA, USA
q
Faculty of Medicine of University of Porto, Porto, Portugal
r
Department of Radiology, Neuroradiology Section, Stanford University School of Medicine, Stanford, CA, USA
s
Department of Angiology, University Hospital Basel and University of Basel, Basel, Switzerland
t
National Institute of Angiology and Vascular Surgery, Havana, Cuba
u
Laboratory for Atherosclerosis Research, Center for Clinical and Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
v
Department of Radiology and Nuclear Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, the Netherlands
w
Department of Vascular Surgery, University of Maryland, Baltimore, USA
x
Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, Western University, 1400 Western Road, London, N6G 2V4, ON, Canada
y
Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
z
Institute of Biostructures and Bioimaging, National Research Council of Italy, Naples, 80145, Italy
aa
Department of Neurology & Stroke Program, University of Maryland School of Medicine, Baltimore, MD, USA
ab
Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia
ac
Clinic of Vascular and Endovascular Surgery, Athens Medical Group, Greece
ad
Knowledge Engineering Center, Global Biomedical Technologies, Inc, Roseville, CA, USA
ae
Department of Electrical and Computer Engineering, Idaho State University, ID, USA
af
Vascular Service, Veterans Affairs Medical Center, Baltimore, USA
b

J. Pitha was supported by Ministry of Health of the Czech Republic, grant No. NU22-02-00051.
* Corresponding author.
E-mail address: lucasaba@tiscali.it (L. Saba).

☆

https://doi.org/10.1016/j.atherosclerosis.2022.06.1014
Received 30 April 2022; Received in revised form 10 June 2022; Accepted 14 June 2022
Available online 28 June 2022
0021-9150/© 2022 Elsevier B.V. All rights reserved.

L. Saba et al.

Atherosclerosis 354 (2022) 23–40

A R T I C L E I N F O

A B S T R A C T

Keywords:
Carotid artery
Atherosclerosis
US
CT
MRI
PET

Cardiovascular disease (CVD) is the leading cause of mortality and disability in developed countries. According
to WHO, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of
these deaths, 85% were due to major adverse cardiac and cerebral events. Early detection and care for in
dividuals at high risk could save lives, alleviate suffering, and diminish economic burden associated with these
diseases.
Carotid artery disease is not only a well-established risk factor for ischemic stroke, contributing to 10%–20%
of strokes or transient ischemic attacks (TIAs), but it is also a surrogate marker of generalized atherosclerosis and
a predictor of cardiovascular events. In addition to diligent history, physical examination, and laboratory
detection of metabolic abnormalities leading to vascular changes, imaging of carotid arteries adds very important
information in assessing stroke and overall cardiovascular risk. Spanning from carotid intima-media thickness
(IMT) measurements in arteriopathy to plaque burden, morphology and biology in more advanced disease,
imaging of carotid arteries could help not only in stroke prevention but also in ameliorating cardiovascular
events in other territories (e.g. in the coronary arteries).
While ultrasound is the most widely available and affordable imaging methods, computed tomography (CT),
magnetic resonance imaging (MRI), positron emission tomography (PET), their combination and other more
sophisticated methods have introduced novel concepts in detection of carotid plaque characteristics and risk
assessment of stroke and other cardiovascular events. However, in addition to robust progress in usage of these
methods, all of them have limitations which should be taken into account. The main purpose of this consensus
document is to discuss pros but also cons in clinical, epidemiological and research use of all these techniques.

1. Current scenario and evidence

source of symptoms, these patients are candidates for a carotid inter
vention to prevent a secondary stroke [3]. Although imaging for this
indication is most often performed with a carotid duplex ultrasound,
when evaluation of the vessels proximal or distal to the cervical portion
of the carotid artery is required for diagnosis or to plan endovascular or
surgical therapy, additional imaging with CTA, MRA or digital sub
traction angiography (DSA) is indicated [3].
The use of imaging methods for screening for carotid artery disease
in the general population, in particular, to identify significant disease
that will prompt an intervention to prevent a stroke are controversial
[3]. However, targeting selected groups of neurologically asymptomatic
patients is well established. These groups can be high-risk patients aged
>55 years with cardiovascular risk factors, patients with a carotid bruit
on clinical exam, Hollenhorst plaque on fundoscopic examination, and
silent infarction on brain imaging examinations [3].
Finally, surveillance after a carotid intervention is a common prac
tice established on the natural history of ipsilateral restenosis, contra
lateral disease progression, and associated stroke risk.

1.1. Targets of carotid imaging
Detailed imaging assessment of extracranial carotid artery disease is
critical for appropriate risk stratification and management of those
presenting with cerebrovascular ischemia as well as of selected asymp
tomatic individuals [1].
The degree of luminal stenosis in the carotid bifurcation has histor
ically served as the primary imaging feature for determining ischemic
stroke risk and the potential need for surgery. Contemporary multi
modality imaging including ultrasound, magnetic resonance imaging
(MRI/MRA), CT angiography (CTA), and even positron emission to
mography (PET-CT) or PET-MRI methods target more detailed visuali
zation of carotid plaque components that indicate plaque vulnerability
(e.g. maximum plaque thickness and volume, calcification, ulceration,
intraplaque hemorrhage, inflammation, intraplaque neovascularization,
lipid-rich necrotic core, and thin or ruptured fibrous cap) [1] (Table 1).
Not infrequently a carotid scan can indirectly (through flow patterns)
detect the status of other vascular territories or even other abnormal
findings of surrounding structures (e.g. a thyroid nodule) [2].

2. Ultrasound
2.1. Stenosis

1.2. The role of carotid arteries imaging

Grading and stratification of carotid stenosis is manly based on
multiparametric, hemodynamic criteria on Duplex ultrasound [4]
(Table 2). The most important parameters are the measurement of the
peak systolic and the end-diastolic flow velocity within the stenosis. The
accuracy of Duplex ultrasound compared with angiography for detecting
>50% and ≥70% stenosis, respectively, is very good, with a positive
predictive value of >90% and a specificity of >85% [5]. Duplex ultra
sound is recommended as the primary imaging modality to assess the

There are several reasons that require carotid imaging, the pre
dominant being evaluation after a cerebrovascular event but also for
CVD screening, risk stratification, and prevention as well as for sur
veillance after a carotid procedure [1,3].
Imaging of the carotid bifurcation is essential in all patients with
symptoms of cerebral ischemia, whether they present as a TIA or com
plete stroke [1,3]. If significant carotid artery disease is identified as the
Table 1
Main imaging methods for carotid arteries.
Ultrasound
CT angiography
Magnetic resonance
Positron emission tomography
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Table 2
(Duplex-)sonographic criteria for grading internal carotid artery stenosis and markers of carotid plaque vulnerability.
Sonographic marker

Classification/Feature of plaque vulnerability

Grading of internal carotid artery stenosis based on Duplex ultrasound

Degree of stenosis as defined by NASCET
- < 50%: plaque on B-mode, aliasing on color duplex image, PSV <200 cm/s
- 50–69%: PSV 200–300 cm/s, EDV <100 cm/s, PSV ratio (ICA/CCA) ≥ 2
- ≥70%: PSV >300 cm/s, EDV >100 cm/s, PSV ratio (ICA/CCA) ≥ 4
Progression of degree of stenosis (>20%)
Hypoechogenic (echolucent) plaque (type 1 or type 2)
«Grey scale median (GSM)»: GSM <15 (hypoechogenic)
Increased juxta-luminal hypoechogenic (black) area (>6 mm2)
Heterogenic echotexture
Large plaque area (>40 mm2)/total plaque area
Large plaque volume/total plaque volume (3D-ultrasound)
Plaque surface irregularities (<1–2 mm)
Plaque ulceration (>1–2 mm)
Increased IPN on semi-quantitative measurement:
• grade 1: no vascularization
• grade 2: limited or moderate vascularization
• grade 3: extensive vascularization
High IPN on semiautomatic quantitative measurement: e.g. large relative perfused area

Echogenicity on B-mode ultrasound

Plaque burden on B-mode ultrasound including 3D-ultrasound
Carotid plaque surface on Duplex-ultrasound and CEUS
Carotid intraplaque neovascularization (IPN) on CEUS

Peak systolic flow velocity (PSV), end-diastolic flow velocity (EDV), contrast-enhanced ultrasound (CEUS).

extent and severity of extracranial carotid stenosis [6]. Various studies
have also shown that the risk of cerebrovascular events increases not
only with the severity of the stenosis but also with rapid progression of
the degree of stenosis [7,8]. Therefore, patients with an asymptomatic
carotid stenosis (ACS) undergo usually annual ultrasound monitoring.

[24]. Patients in Germany who were treated with lipid-lowering drugs
on the basis of a high CPB had a much lower risk of cardiovascular
events over 3.9 years, than patients treated only on the basis of serum
cholesterol: (5.4% vs 23%, respectively) [25]. It has been supported that
“Treating arteries” without measuring plaque would be like treating
hypertension without measuring blood pressure.” [26].
Studies using CPB identify new causes of atherosclerosis, either
through genetic studies [27], or studies of new risk factors such as toxic
metabolites produced by the intestinal microbiome [28]. Such studies
will lead to new therapies for atherosclerosis, and measurement of CPB
markedly reduces sample size and duration of studies to evaluate such
new therapies [29].
New automated methods based on machine learning for measuring
TPA for measuring TPA, 3D carotid plaque burden [30] and Vessel Wall
Volume [31] (which can be measured in persons without plaque, so it
can replace IMT) will make it much easier to implement this. These new
methods are very fast, reliable, and reproducible [32]. Fig. 1 shows
comparisons of automated with manual segmentation.

2.2. Features of vulnerability
Duplex ultrasound can assess not only the degree of stenosis [4,9],
but also several sonomorphological characteristics which are associated
with plaque vulnerability [10]. Hypoechogenicity including a low grey
scale median (GSM) [11,12], large juxtaluminal hypoechogenic area
[13], heterogeneous echotexture [14,15], or higher plaque burden
(plaque area, total plaque area [TPA], or plaque volume) [16,17], sur
face irregularities and ulceration [14] on B-mode ultrasound are sono
graphic features of plaque vulnerability with increased embolic risk [6]
(Table 2).
IMT represents mainly the middle layer of the carotid arterial wall
and is a marker of arteriopathy [18].
According to the American Society of Echocardiography, IMT is a
subclinical vascular disease rather than synonymous of subclinical
atherosclerosis [19]. A 2020 review article summarized many of the
advantages of measuring carotid plaque burden, which is far superior to
measuring carotid IMT in many ways [16].
Carotid plaque burden (CPB) is useful for risk stratification, treat
ment of atherosclerosis, research into the biology and genetics of
atherosclerosis, and evaluation of new therapies against atherosclerosis.
Measured as TPA or as 3D plaque volume, CPB is highly correlated
with coronary calcium [17], and as predictive of events [20]; while IMT
is neither [17,20]. A recent study reported that CPB was superior to
coronary calcium for risk stratification in women [21]; it is also detected
at a younger age. CPB also has significant advantages compared with
coronary calcium, because it can be measured repeatedly, to assess and
adjust the effects of therapy. Serial assessment of plaque burden in
conjunction with life-style and pharmacological treatment according to
guidelines, called “Treating Arteries” (instead of merely treating risk
factors), markedly improves therapy for atherosclerosis. In part this is
because showing patients images of their plaque markedly improves
compliance with lifestyle changes and medication [22]. Among
high-risk patients with asymptomatic carotid stenosis, implementation
of “Treating Arteries” was associated with a >80% reduction of the
2-year risk of stroke/myocardial infarction/vascular death [23]. In
prevention clinics across Argentina, “Treating Arteries” was imple
mented in 2010; among patients age >65, the annual risk of cardio
vascular events declined from 5.85% to 2.35% between 2011 and 2015

2.3. Transcranial Doppler detection of embolic signals in carotid artery
disease
Transcranial Doppler ultrasound (TCD) is a non-invasive technique
that can be used to detect circulating emboli/intracranial embolism.
These emboli appear as short-duration, high-intensity embolic signals/
intracranial embolism and are accompanied by a characteristic chirping
sound. TCD circulating emboli detection has been shown to have a high
sensitivity and specificity in experimental studies [33], although in
clinical practice care needs to be applied in distinguishing true embolic
signals (also known as high-intensity transient signals) from artefact.
Consensus criteria have been developed to allow this [34].
Studies have demonstrated that there were differences in the prev
alence of embolic signal in the different stroke subtypes with a higher
occurrence in large artery stroke in comparison with cardioembolic and
lacunar stroke [35]. In patients with recently symptomatic carotid ste
nosis (SCS), during a 1-h recording from the ipsilateral middle cerebral
artery (MCA) embolic signals can be identified in about 40% of in
dividuals [36]. A higher prevalence has been reported in patients with
more recent symptoms, SCS compared with ACS, and plaque imaging
characteristics indicate a higher risk plaque [37].
Prospective longitudinal studies have demonstrated that asymp
tomatic embolization encountered by TCD predicts future stroke risk in
both SCS [36] and ACS [38–42].
The effect is additive to that obtained by plaque imaging modalities
such as carotid ultrasound [43]. It has been suggested that embolic
25
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Fig. 1. Automated measurement of vessel wall volume.
(A) Automated segmentation (yellow line) was very accurate compared to manual segmentation by experts (red line). Dice-similarity-coefficient (DSC) was 93.2 ±
3.0% for the Medial-Arterial Boundary in the common carotid artery and 91.9 ± 5.0% in the bifurcation. DSC for the Lumen-Intima Boundary was 89.5 ± 6.7% and
89.3 ± 6.8% for the Common Carotid Artery and the bifurcation respectively. Automated segmentation took less than 1 s for each side. (B) Relationships of the
automated and manual VWV measurements for n = 302 3DUS images in the CAIN dataset. (a) Linear correlation (r = 0.876, p = 0.0001), and (b) Bland-Altman plot
of the two sets of VWV measurements. The solid red line and the dash red lines represent the bias (− 3.6 mm3) and mean ± 1.96 SD, respectively. Reproduced by
permission of IEEE from: Zhou R, Guo F, Azarpazhooh MR, Spence JD, Ukwatta E, Ding M and Fenster A. A Voxel-Based Fully Convolution Network and Continuous
Max-Flow for Carotid Vessel-Wall-Volume Segmentation From 3D Ultrasound Images. IEEE Trans Med Imaging. 2020; 39:2844–2855. (For interpretation of the
references to color in this figure legend, the reader is referred to the Web version of this article.)

signal detection may be a useful method to identify ACS patients at high
risk who may particularly benefit from carotid endarterectomy (CEA)
[41] although this needs to be proven in a randomized intervention
study. Conversely, patients with an absence of embolic signals may do
well with intensive medical management alone.
Embolic signal detection has been used to evaluate the effectiveness
of antithrombotic drugs in carotid artery disease [40]. Studies have
shown that aspirin, clopidogrel but also statins reduce embolic signals
[40,44,45]. Combination antiplatelet regimens such as aspirin and clo
pidogrel were more effective than aspirin alone in randomized
controlled trials [40,46]. This paralleled subsequent studies demon
strating their greater effectiveness in preventing recurrent stroke after
minor stroke and TIA [44,46], and reinforcing the evidence that embolic
signal detections may be a useful surrogate marker to identify the effi
cacy of antithrombotic agents.

2.4. Impact of contrast material
As a complement to conventional duplex ultrasound, intravenous
application of ultrasound contrast agents has greatly enriched sono
graphic imaging in vascular medicine [47,48]. Contrast agents consist of
small microbubbles, which circulate strictly intravascularly in the
bloodstream for several minutes after application. Due to their
non-linear reflection pattern, a contrast-specific ultrasound image is
obtained, which enhances not only the vessel lumen but also the
microcirculation in the vessel wall (vasa vasorum) including intraplaque
neovascularization (IPN) [49].
In the carotid artery, contrast-enhanced ultrasound (CEUS) is helpful
in distinguishing complete vessel occlusion from very high-grade carotid
stenosis. In addition, particularly hypoechogenic plaques can be well
detected and surface irregularities and ulcerations of arteriosclerotic
lesions can be better delineated [50–52]. The most important value of
CEUS lies in the detection and quantification of IPN [48], which is
usually performed semiquantitatively [53,54]. Such visual-based
26
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quantification has good intra- and interobserver variability, but a more
objective, purely quantitative measurement of IPN ranging from mea
surements of maximal contrast enhancement to automated,
computer-assisted quantification of the relative perfused area is desir
able [55–57].
IPN on CEUS has been compared with the corresponding vasculari
zation on histopathologic examination in patients with carotid stenosis
before CEA showing a good correlation between the IPN and the extent
of microvessels and inflammation within the plaque on histology
[58–60].
It has been demonstrated that hypoechogenic plaques, which were
considered vulnerable on B-mode ultrasound, had higher IPN on CEUS
than the more stable hyperechogenic lesions [53,58]. Various retro
spective studies of patients with carotid plaque revealed that those le
sions with a higher embolic risk had increased plaque IPN on CEUS
imaging. Thus, it was shown in a meta-analysis that the prevalence of
IPN was higher in SCS compared with ACS patients [15] and correlates
with cardiovascular events [61]. Different prospective studies also
demonstrated that in patients with a recent ischemic cerebrovascular
event the risk of future ischemic stroke or TIA was significantly associ
ated with IPN in carotid CEUS examination [62,63]. IPN on CEUS im
aging was also found to be predictive of significant and complex
coronary artery disease and future cardiovascular events [64].
Carotid CEUS examination has the potential to improve risk strati
fication with respect to the occurrence of embolization by grading IPN in
patients with carotid plaque and stenosis. This could be useful to
monitor therapeutic interventions [65] and to better select patients with
carotid stenosis, who benefit from a possible invasive therapy [49].

combined approach of pre-contrast CT to detect hemorrhage and man
ifest infarction, perfusion CT measurements to differentiate between
penumbra and infarct, and CTA to detect the occluded vessel as well as
potential concomitant carotid abnormalities.
3.2. Features of vulnerability
Atherosclerotic disease is a complex, heterogeneous, and multifac
torial condition with several types of components in the same plaque.
The role of plaque imaging is to identify those imaging biomarker fea
tures of carotid plaque that are related to vulnerable plaque [76–79]. In
particular, CTA thanks to its spatial resolution is able to assess the ca
rotid artery lumen and the arterial wall.
A key feature of vulnerable carotid plaque is Intraplaque hemorrhage
(IPH), which is defined by the accumulation of blood components within
the carotid plaque [80]. Regarding the pathogenesis of IPH, most of the
authors suggest that it is linked to the rupture of neovessels or plaque
rupture itself, and some trigger events including inflammation, meta
bolic diseases or diabetes may precipitate this condition [80]. IPH rep
resents the strongest imaging feature associated with the occurrence of
stroke [81], and it is also more common in carotid artery ipsilateral to
embolic stroke of undetermined source [82]. Conflicting results have
been reported about the role of CT to detect this feature. However,
studies suggest that CTA is able to discriminate the presence of IPH, both
directly according to attenuation at 25 HU [83] and indirectly with the
presence of calcified rim and soft internal plaque [84].
The thin fibrous cap with a lipid-rich necrotic core (LRNC) represents
one of the most important features of the carotid artery vulnerable
plaque model. In particular, LNRC is considered a collection of hetero
geneous tissue composed of cholesterol crystals and necrotic debris of
apoptotic cells [85].
The fibrous cap is a layer of fibrous connective tissue that contains
macrophages and smooth-muscle cells, and particularly the morphology
and thickness of the fibrous cap are indicative of rupture [86]. These two
imaging features are associated with the risk of stroke, especially when a
thin fibrous cap covers a large LRNC [87].
In addition, the LRNC size correlates with future ipsilateral carotid
symptoms [88]. CT can be used to visualize lipid components of the
LNRC, thanks to lipid tissue attenuation properties, but may more hardly
discriminate between LRNC and IPH, given the attenuation values of
these two features [88]. Similarly, the evaluation of the fibrous cap with
CT is not considered optimal because of the artefact related to
halo-effect and edge-blur [89].
Another feature of plaque vulnerability is inflammation of the ca
rotid artery plaque. Different types of inflammatory cells have been
identified in the carotid plaque usually located in the plaque shoulder,
cap, or both with a role in plaque “instability” [89,90]. Beyond the
presence of macrophages, plasma cells are also associated with the risk
of rupture and the occurrence of cardiovascular events [90].
Similarly, plaque neovascularization is considered a marker of pla
que vulnerability, which is related to newly formed neovessel arising
into the intima and is associated with plaque activity [88]. The presence
of neovascularization in carotid plaque represents an element of insta
bility because these microvessels are prone to rupture due to their
immature and imperfect endothelial structure [91]. CTA can identify the
presence and the degree of neovascularization thank its ability to detect
contrast plaque enhancement [92].
Beyond plaque composition, vulnerable plaques tend to be associ
ated with plaque surface morphology (i.e. smooth, irregular, or ulcer
ated) [77]. In particular, the presence of ulceration, defined as an
intimal defect larger than 1 mm in width [88], is considered a risk
feature for cardiovascular events [93]. The carotid plaque surface
morphology can be better assessed with CTA in comparison with other

3. Computed tomography
3.1. Stenosis
CTA has evolved along with the technological advances of CT
hardware and software. Modern CTA, performed with multidetector
high-speed CT hardware and evaluated with 3D reformatting software,
accurately and reliably depicts carotid disease and allows for direct
quantification of carotid stenosis in millimeters [66–72].
CTA is an anatomic study of arteries, allowing for direct evaluation of
carotid stenosis. CTA is fast, with images of the head and neck acquired
over approximately 5–15 s during contrast injection. 512 × 512 memory
matrix multidetector CT scanners allow acquisitions with near-isotopic
spatial resolution and an effective section thickness as small as 0.5
mm [73]. For evaluation of carotid arteries and the cerebral vasculature,
it is possible to narrow the nominal section thickness to obtain a sub
millimetric dataset. This ability, combined with 3D image rendering,
provides excellent accuracy for the measurement of the degree of ste
nosis [73]. In light of the relative benefits of CTA in reference to safety,
time, and related lower cost than DSA, it is compelling to use CTA when
the indication for angiography is not to deliver a therapeutic interven
tion such as stenting but to accurately characterize the degree of ste
nosis. Venous filling is not an artefact for neck carotid imaging, because
arteries are easily recognized as distinct from veins.
CTA evaluation is mainly based on axial sections and curved planar
reformations (CPR). CTA has been shown to have a pooled sensitivity of
95% and specificity of 98% for the detection of >70% stenoses [74].
There are advantages of quantifying carotid stenosis by direct millimeter
measurements instead of or in addition to the well-known North
American Symptomatic Carotid Endarterectomy Trial (NASCET)–style
ratio calculations [75]. Multi-slice CTA can in addition detect tandem
stenoses in the region of the carotid origin from the aorta, the carotid
siphon, and the intracranial portion of the carotids. CT is able to provide
a comprehensive evaluation of patients with acute stroke by using a
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Table 3
CT features of plaque vulnerability and its strengths and limitations.
Intraplaque hemorrhage
Lipid-rich necrotic core
Plaque inflammation
Neovascularization
Plaque surface
morphology
Plaque volume and
composition
Calcifications

Imaging features

Supporting evidence

Limitations

General limitations

Directly: attenuation values ≤ 25
Indirectly: calcified rim and soft
internal plaque
Presence of soft plaque components

Moderate
supporting evidence

Similar HU attenuation values between
soft plaque components

Conflicting
supporting evidence
Weak supporting
evidence
Moderate
supporting evidence
Strong supporting
evidence
Strong supporting
evidence
Strong supporting
evidence

Artefact related to halo-effect and edgeblur

•Radiation dose delivered to the
patients
•Potential side effect
•The limit tissue constrast between
soft plaque components
•Overstimates the degree of the
stenosis due to calcium deposits

Presence of contrast plaque
enhancement
Presence of contrast plaque
enhancement
Alterations of the luminal surface on
the luminal profile of the plaque
Size of the carotid plaque with its
subcomponents
Size and morphology of calcium
deposits

Presence of a halo or edge blur may
hinder detection of smaller ulcerations
Limit tissue contrast attenuation in some
plaque subcomponents

non-invasive imaging modalities, as demonstrated by Saba et al. [94,
95].
Also, carotid plaque volume is a crucial determinant of plaque
vulnerability. Rozie et al. demonstrated that plaque volume and the
relative subcomponents of the plaque are associated with plaque
vulnerability and stroke [96]. Thanks to its excellent spatial resolution,
CTA can easily evaluate this parameter [76].
Among the multiple parameters that have been indicated as
responsible for an increased vulnerability, conflicting results have
emerged in the identification of a role for calcium. Emerging research
has suggested various mechanisms in calcium deposition leading to
different phenotypes of carotid plaque calcification [97–101]. Yang
et al. investigated the association between calcium configurations and
ulceration with IPH, demonstrating that superficial, multiple, and thin
calcifications were associated with IPH. The authors concluded that the
size and location may represent a marker of high-risk plaque [98].
Table 3 summarizes the CT features of plaque vulnerability and its
strengths and limitations.

which can include entities like fibromuscular dysplasia, Marfan syn
drome, and Ehler-Danlos syndrome [102,103]. It is important to scru
tinize the other cervical arteries as well, as they may exhibit
morphological changes contributing to a correct diagnosis (e.g. signs of
fibromuscular dysplasia in the contralateral artery) [104].
The pathophysiology of a carotid dissection explains its imaging
findings [103]. In contrast to the aorta, the dissection flap is seldom seen
in a carotid artery dissection, as the false lumen usually thromboses and
creates a semicircular non-enhancing soft tissue density surrounding the
true lumen (Fig. 2) [103]. This makes MR-imaging especially useful, as
this thrombus will lead to a hyperintense signal on fat-suppressed
T1-weighted images due to blood breakdown products. It can be
problem-solving in cases in which the presence and extent of the
dissection can be difficult to assess on CT alone, as the difference in
contrast between the wall hematoma and surrounding tissues can be
limited [103].
A carotid dissection usually appears in the supra-bulbar internal
carotid artery. In many cases, it will remain limited to the extracranial
segment, but extension into the skull base can occur [103,104].

3.3. Ancillary findings in carotid imaging

3.3.2. Carotid web & thrombus
A carotid web is identified as a small, (curvi)lineair soft tissue density
protruding into the carotid lumen usually at the level of the carotid bulb
[105,106]. According to some authors, it represents a variant of fibro
muscular dysplasia and is associated with an increased risk for stroke,
especially in younger patients without classic vascular risk factors
[107].
A thrombus presents as a non-enhancing central structure sur
rounded by flowing blood (the so-called “donut” sign). While rare, its
presence is important as it is associated with an increased risk for stroke,
but also with conditions leading to a hypercoagulable state like malig
nancy, infections, and pregnancy [105,106].

While evaluation of vessel patency and plaque characteristics re
mains the main reason to perform CT/MR-imaging of the carotid ar
teries, a variety of ancillary findings can be encountered (Table 4). Some
are merely incidental findings with no further clinical relevance, while
others represent a different etiology of the patient’s complaints with
clear implications for further treatment and prognosis. Although a
detailed scope of all possible ancillary findings is outside the scope of
this paper, some important entities will now further be discussed.
3.3.1. Carotid dissection
As in the aorta, a dissection of the carotid artery wall constitutes a
disruption of the carotid intima layer, with blood flowing into the vessel
wall and the creation of a true and false lumen [102].
A carotid artery dissection can be spontaneous or post-traumatic
[102]. When spontaneous, an underlying condition must be ruled-out,

3.3.3. Inflammatory and infectious conditions
Carotid vasculitis can be defined as the inflammation of carotid ar
tery walls with or without necrosis, leading to stenosis or occlusion of

Table 4
Ancillary findings.
Condition

Comments

Congenital
Inflammatory & infectious conditions

Agenesis, aplasia or hypoplasia of ICA
Carotidynia
Giant cell arteritis
Takayasu arteritis
Post-radiation arteritis
Traumatic or spontaneous
Consider underlying condition with spontaneous (e.g. FMD)
Associated with increased stroke risk

Carotid dissection
Carotid web & floating thrombus
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Fig. 2. Carotid artery dissection (A and B) in a 49-year-old female patient.
The CTA shows the filiform lumen in the right ICA (A) that is confirmed by the MR B). Infective pseudo-aneurysm in 63-year-old male patient (C and D). The CTA
shows the contrast material due to into the pseudoaneurysm (white open arrows, C) and the volume rendered image (D) confirms the spatial relationship.

the lumen [108]. Vasculitis may be associated with systemic connective
tissue disorders or may be secondary to infection, malignancy, drugs, or
radiation therapy [108]. For a correct diagnosis, relevant laboratory
tests are also required. The 2012 Chapel Hill Consensus Conference
defined different types of vasculitis in terms of (a) the size of the
involved arteries and (b) associated pathologic lesions [109]. The most
frequent vasculitis involving carotid arteries are Takayasu arteritis and
Giant cell arteritis [108,109]. Infectious extracranial carotid disease is
rare and usually caused by Staphylococcus aureus, Salmonella, and
streptococcus species. When present, it can manifest as an infected
aneurysm with a focal weakinging of the wall, development of a
pseudo-aneurysm, and increased rupture risk (Fig. 2).
With CTA/MRA imaging, signs of carotid vasculitis are vessel wall
thickening (mostly concentric representing a key parameter in the dif
ferential diagnosis) and contrast enhancement. Usually there is no
preference for the involvement of the carotid bifurcation (different from
atherosclerotic disease). In the case of active vasculitis contrast
enhancement of the thickened vessel wall may be seen on both CT and
MR [108].

4. Magnetic resonance imaging
4.1. Stroke risk assessment and characterization of low-grade carotid
atherosclerosis
Risk assessment of carotid atherosclerotic plaque for cerebrovascular
ischemic events has historically relied on angiographic measures of
stenosis, with thresholds for revascularization defined by randomized
clinical trials that date back to the early 1990’s [93,110,111]. The
established threshold for SCS is 70%, although revascularization is often
considered for stenosis beginning at 50% when symptomatic and 60%
when asymptomatic [93,110,112,113]. Stenosis has worked well in
these studies considering it is a surrogate for plaque burden, which is
strongly associated with ischemic stroke risk [16]. However, there have
been substantial technical advances in our ability to identify features of
atherosclerotic plaque that can improve our precision for stratifying risk
[114–116]. This is especially important for atherosclerotic plaques that
fall under the thresholds for angiographic detection of risk. Risk esti
mation for stroke from a plaque causing less than 50% stenosis must be a
priority considering the high prevalence of low-grade carotid stenosis in
the community [116]. For example, in the Cardiovascular Health Study
detectable carotid stenosis was present in 62% of women and 75% of
men aged ≥65 years, with only 7% of men and 5% of women having
stenosis ≥50% [117]. Risk analysis of carotid plaque must also consider
the accommodation of atherosclerotic plaque formation by

3.3.4. Other
Any other condition or anomaly that is encountered during a carotid
examination must be reported. These include rare instances like carotid
body tumours or any other condition that influences clinical
management.
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intracranial plaques can be measured with quantitative MRA which
combines traditional MRA-Time-of-Flight (TOF) and contrast-enhanced
(CE)-MRA. This technique allows quantification of the hemodynamic
significance of a plaque, which may not necessarily correlate with the
degree of narrowing [135].
Aortic arch atheroma has been recognized as a potential cause of
emboli in patients with cryptogenic stroke and MRI-based multicontrast
plaque imaging was used to recognize vulnerable aortic arch plaques
[136]. The addition of 4D flow measurements identifies potential
embolization pathways to the brain and is especially useful to suggest
possible retrograde embolization in patients with vulnerable plaques
located in the proximal descending aorta immediately distal to the
origin of the large extracranial arteries [136].

flow-mediated outward remodeling regulated by endothelial cells to
preserve lumen caliber. This endothelial response is overcome once
plaque size reaches a threshold and angiographic stenosis becomes
detectable. For example, there is evidence that angiographic narrowing
of the extracranial internal carotid artery is not detected until plaque
burden reaches 61.9% [118] or 63.1% [119] area stenosis measured on
black blood MRI exams, highlighting the large burden of plaque that can
exist in low-grade carotid atherosclerosis.
4.2. High-risk carotid plaque features detectable on MRI
Based on histopathologic validation studies [120], MRI has been
shown to have high accuracy in detecting key high-risk carotid plaque
features. For example, using a multi-sequence protocol with a carotid
coil, MRI can identify the presence of an LRNC, thinning/rupture of the
fibrous cap, ulceration, and IPH, all of which are strong predictors of
future stroke risk [114]. Although the literature strongly supports a
potential role for multi-contrast, multi-sequence MRI to aid in risk
stratification before stroke and identify culprit lesions after stroke,
adoption of these techniques has been limited in the context of acute
stroke imaging due to exam length, need for dedicated coil hardware
and/or gadolinium, and complexity in image interpretation [121].
In recent years, converging evidence has identified the use of a single
T1-weighted, fat-suppressed sequence to identify IPH as a particularly
valuable imaging strategy to incorporate into clinical practice [122].
This sequence includes an inversion pulse to suppress the blood in the
lumen. In such an approach, IPH can be identified by the presence of
T1-hyperintense signal within carotid plaque when noted to be brighter
than the signal intensity of adjacent background skeletal muscle [123,
124]. A recent meta-analysis of individual patient data of 560 patients
from 7 cohort studies showed the annualized rate of ipsilateral stroke in
those with carotid IPH to be markedly increased compared to those
without IPH across all stenosis severity levels, including those with
<50% stenosis [125]. For this reason, MRI-based IPH identification has
significant promise not only in identifying patients who may benefit the
most from surgical revascularization procedures, but also in identifying
culprit low-grade plaques responsible for ischemic strokes which would
otherwise be characterized as cryptogenic in nature [126,127]. Patients
with an absence of IPH may do well with intensive medical management
alone. Given the promise of carotid IPH as a clinically useful MRI risk
marker, randomized stroke prevention trials using IPH as a selection
criterion will be needed to establish whether there is evidence to support
the widespread adoption of this approach in clinical treatment
decision-making.

5. Other techniques
5.1. PET
PET enables molecular imaging of biological and biochemical pro
cesses in vivo, whereas hybrid PET/CT [137] or PET/MRI [138,139]
also provides additional information on plaque morphology. The
glucose analogue 18F-Fluorodeoxyglucose (FDG) is taken up by cells
with a high metabolic rate, such as macrophages within an atheroscle
rotic plaque, and therefore enables to quantify the inflammatory activity
within carotid atherosclerotic plaques [140]. In order to correct for
uptake of the tracer in the blood pool, it is recommended to use the
target to background ratio (TBR) to quantify FDG uptake [141]. TBRmax
is defined as the ratio of the maximal standardised uptake value (SUV
max) measured in the plaque and the mean SUV (SUVmean) in the blood
pool [141]. In a study of 49 patients that underwent an 18F-FDG PET
examination before CEA, it was shown that the TBRmax correlates with
the extent of CD68 staining, a measure for macrophage content of the
plaque (r = 0.51, P < 0001) (Fig. 3) [142]. Various studies demonstrated
higher uptake in symptomatic compared to asymptomatic plaques,
while the activity in symptomatic plaques decreases in the months after
the event [142–146]. Moreover, several studies reported weak correla
tions between 18F-FDG uptake on PET and CT/MRI parameters of ca
rotid plaque (Spearman ρ: 0.098–0.39), indicating that PET may have
additive information for risk assessment [143,147,148]. Importantly,
18F-FDG uptake was demonstrated to predict early post-PET stroke
recurrence with a fully adjusted hazard ratio of 4.57 (95% confidence
interval [CI], 1.5–13.96; p = 0.008) in a pooled cohort of 196 patients
with carotid stenosis and recent stroke/transient ischemic attack with 8
post-PET stroke recurrences. Although most extensively validated, a
disadvantage of 18F-FDG is that the tracer is not specific. Recently, more
specific tracers for plaque inflammation have been proposed [149–151],
but these still need to be validated in larger studies. Alternatively, up
take of [1]⁸F-sodium fluoride (NaF), a marker for active microcalcific
processes, was reported at the site of carotid plaque rupture and larger
uptake was demonstrated in symptomatic plaques [142,152,153]. The
value of 18F–NaF for risk stratification is currently under investigation
in an ongoing prospective multicenter trial (PREFFIR; unique identifier:
NCT02278211).

4.3. Role of MRI in assessment of intracranial carotid and aortic arch
atherosclerosis
MRI technology has been shown to have an increasing clinical role in
the evaluation of atherosclerotic plaques in locations other than the
extracranial carotid artery. MRA has high sensitivity and specificity for
identification of stenoses >50% involving the intracranial ICA [128,
129] and the MCA [130]. It is routinely utilized in clinical practice to
identify patients suspected of harboring intracranial stenosis. Limita
tions of intracranial MRA include long acquisition times and over
estimation of the degree of stenosis because of flow artefact.
A major advantage of MRI sequences in the assessment of intracra
nial plaques is the concomitant acquisition with parenchymal brain
imaging. Recent MRI techniques also allow for further characterize
plaque composition and its hemodynamic effects. High-resolution vessel
wall MRA provides further characterization of the intracranial arterial
wall and pathology by suppressing signal from intravascular blood. It is
increasingly used to differentiate among different causes of intracranial
steno-occlusive disease and to identify/characterize plaques causing
minimal or no narrowing on luminal imaging in patients with otherwise
unexplained ipsilateral stroke [131–134]. The hemodynamic effects of

5.2. Intravascular imaging platforms
The use of intravascular technologies for intraluminal imaging of
carotid atherosclerosis is currently limited to highly selected cases and
includes fiber-bundle angioscopy (FBA), IVUS, and optical coherence
tomography (OCT). FBA was introduced in the early 1980s and initially
applied to assess plaque disruption, luminal thrombus, and stent
placement [154,155]. Despite the initial enthusiasm given the unprec
edented images of the arterial lumen and surface, the poor image quality
(<10,000 pixels even with FBA), the large size, and the excessive stiff
ness of the cameras significantly limited adoption [156]. Recent ad
vances in photonics and optics allowed the development of Scanning
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Fig. 3. Metabolic activity within
atherosclerotic carotid plaque, imaged
with [18F]-fluorodeoxyglucose (18FDG)
hybrid PET/CT correlates with ex-vivo
macrophage-specific CD68 CT angiog
raphy (axial plane) fused with [18F]fluorodeoxyglucose PET in a patient
with a symptomatic right internal carotid
artery plaque (arrow).
From the fused PET/CT images, there are
small regions of calcification with a nar
rowing of the right internal carotid ar
tery. The tissue to blood ratio for
maximum 18FDG uptake was 4.7.
Following excision and advanced immu
nohistology, there is strong evidence for
extensive CD68 staining (rust-stained re
gions), a marker of macrophage expres
sion and direct inflammatory burden.
Reproduced with permission of Elsevier
from: Cocker MS, Spence JD, Hammond
R et al. [18F]-Fluorodeoxyglucose PET/
CT imaging as a marker of carotid plaque
inflammation: Comparison to immuno
histology and relationship to acuity of
events. International Journal of Cardiol
ogy. 2018; 271:378–386.

Fig. 4. (A) Laser-angioscopy showing an acutely disrupted plaque with red blood cell rich intraluminal thrombus resulting in critical stenosis; (B) IVUS images with
doppler mode of a symptomatic calcified plaque causing severe irregular stenosis; (C) OCT images showing stent apposition in a carotid artery. (For interpretation of
the references to color in this figure legend, the reader is referred to the Web version of this article.)

Fiber Angioscopy, a miniature laser-based platform capable of gener
ating high resolution (~12 μm, or >250,000 pixels) structural,
biochemical, and biological vascular videos in real time (Fig. 4A) [156,
157]. IVUS was introduced in the late 1980s and employs an intravas
cular piezoelectric transducer that creates waves that propagate through

blood and tissue. IVUS generates cross-sectional imaging without the
need of clearing the intravascular blood, but the resolution is poor
(100–150 μm). IVUS has been clinically used to characterize the struc
ture of carotid plaques by virtual histology, measure the degree of ste
nosis, and evaluate stent apposition and plaque protrusion in CAS
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scanning protocols. Current measurement methods are time-consuming
and do not utilize the power of knowledge-based paradigms such as
artificial intelligence (AI), a branch of computer science that includes
machine learning (ML), deep learning (DL), and convolutional neural
networks (CNNs) (Fig. 5). AI excels at automatically recognizing com
plex patterns and providing quantitative assessment for imaging data,
showing high potential to assist physicians in acquiring more accurate
and reproducible results [170,171]. Recently, a DL–based model was
applied for carotid IMT and lumen measurement [172]. It was the first
artificial intelligence-based approach to ultrasound-based carotid artery
segmentation and carotid IMT (cWT þ CP) measurement that used 13
layers of convolution layers for feature extraction and three up-sample
layers for segmentation. Deep learning resulted in a useful tool for ca
rotid ultrasound-based characterization and classification of symptom
atic and asymptomatic plaques in a more recent paper [173] where
implementation with a supercomputer configuration was more precise
and faster if compared with other AI systems. Further and more accurate
measurements can be obtained when an AI-based model utilizing DL
methodology is used on image patches rather than full-size images,
mainly to have better local control in small regions rather than the
whole image at once [170,172,174]. A new method consisting of a novel
design of 10 types of solo deep learning (SDL) and hybrid deep learning
(HDL) models focused on automated plaque segmentation in the internal
carotid artery (ICA) has shown to be very useful in identifying plaques at
risk of rupture: the system is very fast and precise (it takes <1 s per
image) and it may therefore be practical to introduce such an AI-based
system to detect rupture-prone plaques (or vulnrable plaque detection)
[175].
In addition to the improved ability to define so-called vulnerable
plaques to enable the best therapeutic approach, AI has also proved to be
useful for the evaluation of carotid artery stenting (CAS) prognosis and
in the prediction of persistent hemodynamic depression after carotid
angioplasty [176,177]. Of note, the application of AI to ultrasono
graphic diagnostics for better diagnosis and possibly new classification
and standardization methods [178] requires close collaboration among
computer scientists, clinical investigators, clinicians, and other users in
order to identify the most relevant problems to be solved and the best
approach and data sources to achieve this.
An AI-based approach has also proven its usefulness in CT. Acharya
et al. investigated a supervised-learning model to classify carotid artery
images into symptomatic and asymptomatic using a combination of
local binary model and wavelet energy features [179]. The authors re
ported sensitivities, specificities, and accuracies of 0.88, 0.865, and
0.902, respectively [179]. Dos Santos et al. proposed a fully-automated,
user-independent tool for the segmentation and analysis of atheroscle
rosis in the extracranial carotid arteries, reporting performance of 83%
with accuracy, sensitivity, and specificity values of 71%, 83%, and 25%,
respectively with an average difference between manual and automated
analysis of 37% (p = 027) and an average analysis time of 1381 s per
patient [180]. AI models have been also developed to simplify plaque
characterization and predict histological plaque composition. Hanning
et al. tested an ML-based analysis of admission non-contrast CT and CTA
to predict thrombus composition with its fractions of fibrin and red
blood cells [181]. This analysis included 112 patients who underwent
thrombectomy due to carotid or middle cerebral artery occlusion,
evaluating both vessel walls, thrombi, and peri-vascular tissue response.
The ML-based algorithm demonstrated an AUC of 0.83 for differenti
ating thrombi with a high fraction of red blood cells (sensitivity and
specificity of 77% and 74%, respectively) and an AUC of 0.84 for
differentiating fibrin-rich thrombi (sensitivity and specificity of 81% and
73%, respectively) [181]. Another research investigated the ability of a
DL-based model to identify symptomatic patients from asymptomatic
patients and further discriminate between culprit and non-culprit ca
rotid arteries in symptomatic patients [182]. This proposed model was
92% accurate in differentiating between symptomatic and asymptom
atic patients, and 71% accurate in discriminating between culprit versus

(Fig. 4B) [158–160]. OCT shines a near-infrared laser sideways and a
small portion of this light (scattering) that reflects from sub-surface
tissues is collected and processed by interferometry. Automated pull
back in a bloodless lumen results in cross-sectional images of arteries.
The use of OCT in carotid arteries continues to be very limited in the
evaluation of disrupted plaques, stent apposition, and tissue prolapse in
CAS [161,162].
6. A look into the future
6.1. Artificial intelligence
As stroke is the second leading cause of global mortality, this
demonstrated the need for improved tools in the management of
occlusive vascular disease [163,164]. Patients with cardiovascular dis
ease leading to stroke often require significant medical imaging in the
acute, sub-acute, and chronic settings, using a range of imaging mo
dalities. Vascular imaging is then used as a key source of information in
the determination of appropriate clinical management. In the era of
modern medicine, AI is an evolving field that is experiencing a steady
development in vascular imaging [79,165,165,166]. In daily clinical
practice, plaque assessment is performed through manual measurement
of the degree of the stenosis and visual evaluation of plaque composition
[6,167]. However, a manual evaluation has various limitations,
including a long analysis time and is highly dependent on the operator.
AI may evaluate carotid plaques with their vulnerable features to decide
whether invasive investigation and treatment are necessary.
US is the modality of choice for initial evaluation and confirmation of
carotid artery disease: characteristics of the carotid plaque in patients
with carotid stenosis can identify those patients with relatively higher
risk for stroke and help select patients who may benefit from interven
tion over medical treatment alone or vice versa. Symptomatic plaques
tend to produce more tight stenosis, be more hypoechoic, have a large
juxtaluminal black area close to the lumen without a visible echogenic
cap, and discrete white hyperechoic areas compared with asymptomatic
plaques [168,169]. Additional and more precise information can be
derived from software implementations applied to ultrasound: 3D/4D,
Intravascular Ultrasound (IVUS), CEUS, Sonoelastography, Vector
Doppler, Grayscale Median (GSM), Radiofrequency, etc. The large
datasets obtained from all these imaging sources are traditionally
interpreted qualitatively by clinicians but are highly heterogeneous,
varying due to differences in patient, imaging technology, and site

Fig. 5. Venn diagram illustrating the hierarchy of the artificial intelli
gence fields.
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non-culprit carotid arteries in symptomatic patients [182]. The rela
tionship between carotid vessel image parameters and stroke risk was
also investigated by Lal et al. using an artificial intelligence algorithm
for risk stratification in carotid atherosclerosis incorporating a combi
nation of carotid plaque geometry, plaque composition, patient de
mographics, and clinical information [183] AI is able to mesh a large
amount of quantitative imaging data to clinical parameters, that may be
a new frontier of AI in carotid plaque risk assessment improving diag
nosis and decision-making in daily clinical practice.
AI is transforming most healthcare domains including carotid MRI.
AI is increasingly used to reduce manual effort in carotid MRI mea
surements. Using a convolutional neural network (CNN) based algo
rithm called DeepMAD to separately segment the carotid lumen and
outerwall contours on 2D T1w turbo spin-echo MRI, Wu et al. identified
slices with atherosclerotic plaque [184]. Similarly, Samber et al. used
two separate CNNs for lumen and outerwall segmentation of 2D T2w
turbo spin echo MRI [185]. Chen et al. demonstrated a CNN algorithm
called LATTE for segmentation [186] of the carotid vessel wall on
3D-MERGE [187] black-blood MRI using a polar transformation
centered on the carotid after vessel identification. To make the seg
mentation robust to inter-scanner differences, domain adaptation for
LATTE was developed and shown to improve the identification of
advanced plaque [188]. Thus, quick, and automated screening for ca
rotid plaque using 3D-MERGE is made possible by LATTE. The next
frontier for carotid AI applications lies in plaque component segmen
tation. CNN-based segmentation of plaque components such as
lipid-core, calcification, and intra-plaque hemorrhage on multi-contrast
2D MRI is able to better match the human expert’s plaque component
segmentation than non-CNN methods [189]. Zhang et al. compared
several ML methods [190] for plaque component segmentation using a
specific sequence called SNAP [191]. However, these methods are 2D
MRI based and need to be modified for use with 3D carotid MRI. With
future development, multi-contrast 3D plaque component segmentation
may allow complete carotid plaque analysis and quantification with
minimal user intervention thereby reducing clinician workloads and
expanding the applications of carotid plaque MRI.
CNNs have also found applications in carotid MRA. Koktzoglou et al.
demonstrated that non-contrast carotid MRI can be accelerated to below
3 min when combined with denoising of MRA using CNNs [192]. Ziegler
et al. used the DeepMedic CNN on CE-MRA to segment the carotid artery
into common, internal, and external carotid segments [193].
Information contained in the grey-scale differences among tissues is
easily summarized by human-derived features. Radiomics can extract
traditional grey scale level features from images to improve the diag
nostic capabilities of carotid MRI. Zhang et al. showed that adding
radiomic features of carotid plaque to traditional plaque features
improved the model’s ability to predict symptom status [190].

Application of such radiomics specific to the carotids requires segmen
tation of the carotid lumen and outer wall. Hence future combination of
CNN based segmentation methods combined with radiomics may enable
a comprehensive and automated analysis of both carotid MRI and other
clinical variables to predict patient outcomes.
6.2. Radiomics
Since the 1990s, the improvement of resolution, which allows the
identification of increasingly smaller lesions, and the availability of
imaging modalities that provide morphological and functional infor
mation have introduced new scenarios and new diagnostic possibilities.
The introduction of new imaging technologies such as ultrasound
contrast agents, microvascular flow, elastography, and specific imaging
processing techniques allows us to obtain improved morphological/
functional quantitative information compared to those only derived
from B-mode.
Precision medicine requires a clear understanding of each patient’s
heterogeneity and individual situation. Radiological images are often
analysed and interpreted by the radiologist only qualitatively (visual
evaluation). However, digital images are composed of individual pixels
to which discrete brightness or colour values are assigned. They can be
efficiently processed, objectively evaluated, and made available at many
places at the same time by means of appropriate communication net
works and protocols, such as PACS and DICOM protocols. In a digital
image, a large amount of numerical data is not analysed by the radiol
ogist. This “hidden” information can be used to create a “radiological
plot”, which can provide much more information on tissue than simple
visual observations by providing objective data. The amount of data
associated with digital imaging has increased and produced a large
amount of electronic data (“Big Data”). In personalized and precision
medicine, the data, analysed with complex mathematical algorithms
and the use of artificial intelligence methods (Fig. 6) [194], can provide
quantitative information on pathophysiological phenomena to improve
diagnostic accuracy, prognostic, and predictive imaging capacity.
Artificial intelligence techniques consist of ML systems. The com
puter receives data and analyses the existing relationships using analysis
systems that reproduce the functioning of the nervous system.
The term “radiomics” was defined by Lambin in 2012 [195] as the
high-throughput extraction of image features from diagnostic images.
The final product is a quantitative feature, measurable and minable,
defined as an “imaging biomarker”. Biomarkers are indicators of normal
biological processes, pathological changes, or pharmaceutical responses
to a therapeutic intervention [196,197]. Therefore, radiomics represents
diagnostic and predictive support that, together with other clinical and
genetic investigations, allows the formulation of personalized therapies
and the evaluation of treatment response.

Fig. 6. Basic representation of an artificial neural network with neurons similar to those within a brain.
The left layer of the neural network is called the input layer and contains neurons that encode the values of the input pixels. The right most layer is called the output
layer, which contains the output neurons. The middle contains the “n” number of hidden layers, which perform mathematical transformations of the data.
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The radiomic data are extracted and processed with bioinformatics
tools. They can be combined with other patient data (clinical, bio
humoral, genetic) to develop models to improve diagnostic, prognostic,
and predictive accuracies. Although radiomics is a natural extension of
computer-aided diagnosis and detection (CAD) systems, it is signifi
cantly different from them. CAD systems are usually used for the
detection or diagnosis of disease [198,199] and are directed towards
delivering a single answer (presence or absence of disease). Radiomics is
a process designed to extract a large number of quantitative features
from digital images to generate pathophysiological hypotheses and
provide information on the phenotype and microenvironment. These
features, in conjunction with other information, can be correlated with
clinical outcomes and used for clinical support. Radiomics has the po
tential to help with the diagnosis and visualization of lesion heteroge
neity and may prove critical in the assessment of prognosis, prediction of
response to treatment, and monitoring of disease status. The “omics”
concept readily applies to quantitative tomographic imaging on multiple
levels (one multi-layer or three-dimensional image from one patient may
easily contain millions of voxels). Complex images with
high-dimensional data are generated, corresponding to measurable
biological characteristics.
Radiomics depicts the goal of precision medicine, in which stable,
reproducible, and validated molecular biomarkers are used to predict
“the right treatment for the right patient at the right time” [199,200].
The radiomic process can be divided into five phases [201]: 1) Image
acquisition and reconstruction, 2) Segmentation and rendering, 3)
Feature extraction and qualification, 4) Construction of a database, and
5) Modelling and validation.
The first step in the radiomics algorithm begins with the choice of an
image acquisition protocol. This varies according to the clinical endpoint. However, image acquisition parameters, including radiation
dose, scanning protocol, reconstruction algorithm, and slice thickness,
vary widely in routine clinical practice. Therefore, a comparison of the
features extracted from different methods of image acquisition is not
possible. The radiomic features are generally sensitive to the acquisition
protocols used, only some are stable despite the different image recon
struction settings. Significant efforts are required to identify univocal
acquisition and reconstruction protocols and to match them between
different scanners.
In most patients with carotid stenotic lesions, the volumes of interest
can be identified. Furthermore, the subvolumes within atherosclerotic
plaque, representative of plaque heterogeneity, can be analysed sepa
rately. With this approach, images with different acquisition parameters
can be combined to yield regions with specific combinations of plaque
features (cell density, necrotic core, hemorrhage, atherosclerotic fibrous
cap, flow velocity, etc). Once the volumes of interest have been identi
fied, the segmentation strategy must be chosen. This point is critical as
the resulting feature values depend on the adopted segmentation
methods, which should be stable and reproducible. Usually, manual
segmentation by expert readers is considered the gold standard, but it is
a time-consuming process with high inter-operator variability. Conse
quently, the best compromise has been identified in CAD systems that
work semi-automatically, with subsequent human manual correction.
The use of semi-automated methods has also paved the way for threedimensional (3D) segmentation [200]. Volumetric segmentation al
lows a comprehensive view of the total lesion and burden, a more
complete description of the shape, and a greater number of points
included in the computation of statistical features, leading to more
reliable results that do not suffer from sampling errors. Moreover,
computer-aided approaches reduce the manual workload, allow fast,
and reproducible volumetric segmentation in large cohorts of patients
[200]. From the identified atherosclerotic plaque, multiple quantitative
image features can be extracted, including features that describe the
characteristics of the region under analysis, such as the histogram of
signal intensity, shape, and texture, and descriptors of the position and
its relationships with surrounding tissues. Features can be “semantic” or

“agnostic”. Semantic features are those commonly used by radiologists
to describe regions of interest with qualitative descriptors such as size
and shape. The agnostic features are mathematically extracted in
dicators that are generally not part of the traditional lexicon of radiol
ogists and can be divided into first- and second-order statistical features
[201]. The first-order features describe the intensity histogram by
extracting features such as the maximum and average values in addition
to the causality and asymmetry of the distribution and have the limi
tation of not providing information on the spatial relations between
voxels. This information can be obtained from the statistical features of
the second order, which, using texture analysis methods, describe the
relations between the signal in a voxel and the signal in the neigh
bouring voxels. Overall, each category produces various quantitative
parameters that reflect the specific aspects of a lesion. The power of a
predictive classifier model is dependent on having sufficient data. A
reasonable rule of thumb is that 10 samples (patients) are needed for
each feature in a model based on binary classifiers. Furthermore, the
best models are those that can accommodate additional clinical or
genomic covariates. Radiomics can be performed with as few as 100
patients, although larger data sets provide more power. Radiomic and
non-radiomic features should be combined with the prediction target to
create a single dataset. After identification, features can be included or
excluded from the model. Radiomic features that are well-correlated
with routine clinical feature (such as symptoms) or features not corre
lated with the clinical end-point are excluded. A predictive model of
clinical outcomes is constructed using the features extracted from the
data set. Radiomics produces models for assessing the risk of stroke or
for estimating the probability of patient survival. Independent valida
tion datasets are needed to confirm the prognostic value of the same
radiomic features. Model performance is measured using receiver
operating characteristic (ROC) curve analysis, which measures accuracy
throughout the range of possible model values and identifies the best
cut-off value. The validation of a model must be accompanied by the
verification of its reproducibility by repeating the analyses with the
same procedures on different data sets. It is therefore important to have
a comprehensive and detailed medical image database [202]. Multiple
articles have focused on ML approaches for the role of image processing
in thw prediction of cardiovascular event and demonstrated that can
improve the accuracy of cardiovascular disease prediction and a better
predictive capacity than some traditional risk scores [203–212].
7. Summary and conclusion
Ultrasonography is the first-line imaging modality for the evaluation
of atherosclerotic carotid artery disease, as it is non-invasive, costeffective, readily available, well-tolerated, and safe [213,214].
Anatomic information is provided with traditional B-mode (greyscale)
ultrasound, while hemodynamic information is provided with color
Doppler, power Doppler, and pulsed-wave Doppler technique [213,
214].
The image quality provided by ultrasound can be enhanced by the
use of a contrast agent [214]. The ultrasonographic contrast agent most
often used is microbubbles of an inert gas stabilized by an outer shell
consisting of phospholipids or albumin (e.g. sulfur hexafluoride or
octafluoropropane) [214]. By use of CEUS, the carotid lumen and
adventitia are enhanced, therefore making lumen irregularities more
prominent and consequently more easily detectable [214]. CEUS com
pensates for the inherent limitations of Doppler techniques, such as a
lower signal-to-noise ratio, lower sensitivity for slow flow, and technical
artefacts such as Doppler angle dependence, aliasing, and overwriting
artefacts [214]. Another use of CEUS is the so-called late-phase
enhancement, where the ultrasound examination is performed 6 min
after administration of the contrast material. Late-phase enhancement
suggests an increased inflammatory cell load within the plaque, thus
representing a possible marker for early plaque rupture [214].
Progression of total plaque area and total plaque volume with 3-D
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ultrasound is a more accurate predictor of transient ischemic attacks,
stroke, and death than the conventional color Doppler techniques [215].
Furthermore, 3-D ultrasound may evaluate carotid plaque surface and
may identify carotid ulcers, which are associated with a higher inci
dence of long-term stroke or death [216,217].
By using multiple different high spatial resolution contrast weight
ings, MRI/MRA has the advantage of being able to measure all the
hallmarks of carotid plaque vulnerability, namely carotid plaque
burden, intraplaque hemorrhage, ulcerations, lipid-rich necrotic core,
and thin or ruptured fibrous cap [218]. These imaging parameters could
be included in a clinical risk prediction model to determine a more
personalized stroke risk [218]. Advanced plaques characterized by a
large lipid-rich necrotic core and thinning/rupture of the fibrous cap are
associated with an increased risk of ischemic cerebrovascular events by
3-fold (95% CI: 1.51–5.95) and almost 6-fold (95% CI: 2.65–13.30),
respectively [114]. Moreover, intraplaque hemorrhage on MRI is a
strong and independent predictor for ipsilateral stroke (Hazard Ratio:
11.0; 95% CI: 4.8 to 25.1)125. MRI provides excellent soft-tissue contrast,
no ionizing radiation and is not subject to technical challenges such as
shadowing or blooming artefacts caused by calcium deposits [219]. MRI
is well-validated, highly reproducible, and is recognized as the optimal
imaging modality for non-invasive assessment of plaque composition for
stroke prediction [219].
CTA is less operator-dependent than carotid ultrasound and is also
more quickly performed and more widely available than MRI [220].
CTA evidence of a low-attenuation or “soft” plaque, an increased com
mon carotid artery wall thickness, or plaque ulceration strongly corre
lates with a recent ipsilateral transient ischemic attack or stroke episode
[220]. Evaluation of the presence of a soft, or calcified plaque, plaque
ulceration or increased common carotid artery wall thickness can be
easily performed with high reproducibility without requiring length of
interpretation time or postprocessing software [220]. A recent study
demonstrated that CTA may accurately identify specific markers which
are more predictive of future stroke risk than the percentage of luminal
stenosis, such as the presence of intraluminal thrombus, the maximum
soft plaque thickness, and a thin adventitial calcification (the “rim sign”)
[221]. Thin peripheral calcification may be a marker of chronic
adventitial inflammation and adventitial microvessel leakage has been
implicated in carotid intraplaque hemorrhage [222]. These findings
highlight the ability of CTA to identify plaque features that are strongly
associated with cerebrovascular ischemia.
Identification of IPH using MRI, the presence of carotid plaque ul
ceration, plaque echolucency on Duplex ultrasound, and reduced cere
brovascular reserve are reliable predictors of future cerebrovascular
events and may be used to identify high-risk patient subgroups and offer
them a prophylactic carotid intervention [223]. The 2018 European
Society for Vascular Surgery (ESVS) guidelines for the management of
patients with carotid artery stenosis recommended that in “average
surgical risk” patients with a 60–99% ACS, CEA should (Class IIa; Level
of Evidence: B) or CAS may be considered (Class IIb; Level of Evidence:
B) in the presence of one or more clinical/imaging characteristics that
may be associated with an increased risk of late ipsilateral stroke, pro
vided documented perioperative stroke/death rates are <3% and the
patient’s life expectancy is > 5 years [224]. These clinical/imaging
characteristics included silent embolic infarcts on brain CTA/MRI,
progression in the severity of ACS, a history of contralateral TIA/stroke,
microemboli detection on TCD, the presence of IPH on MRI, plaque ul
ceration on 3D ultrasound or MRI, reduced cerebrovascular reserve, a
large plaque area (>40 mm2) on ultrasound longitudinal images and
plaque echolucency as shown by a low GSM (<30) and presence of a
large (>8 mm2) juxtaluminal hypoechoic area after image normalization
of Duplex ultrasound images [224]. A recent multinational survey of
current practice in carotid imaging reported that the first exam used to
evaluate carotid bifurcation disease in ACS patients was ultrasound in
88.8% of respondents, CTA in 7%, and MRA in 4.2% [225]. Neverthe
less, it is worth mentioning that the percentage of luminal stenosis for

which CEA or CAS was recommended for asymptomatic patients was
reduced in the presence of imaging evidence of “vulnerable plaque
features” by a third of study participants (n = 76 of 223 respondents;
34.2%) [225].
In conclusion, each imaging technique has its advantages and dis
advantages when compared with the other available modalities. Issues
like cost-effectiveness, availability, reproducibility of the results, and
local expertise play an important role, but overall ultrasound should be
considered as the initial imaging modality, followed by CTA or carotid
MRA as second-line imaging options. The presence or lack of specific
imaging parameters should aid physicians and surgeons in their
decision-making and the selection of the optimal therapeutic approach
for each patient, after also considering each patient’s views, needs, and
expectations [226]. There is an urgent need for modernized clinical
prediction models that include imaging parameters on plaque vulnera
bility to determine a personalized stroke risk. Trials are warranted to
investigate whether including these imaging parameters in clinical
decision-making reduces stroke risk and improves the outcome of the
patients.
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